NCT00612508View on ClinicalTrials.gov

Hormonal Contraception and Vaginal Health

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Contraceptive UsageVaginal Epithelial Disruption
Interventions
DRUG

Desogen (ethinyl estradiol and desogestrel)

1 tablet every day; each tablet contains 0.15mg desogestrel and 0.03mg ethinyl estradiol

DRUG

NuvaRing (ethinyl estradiol and etonogestrel)

Place the ring in the vagina for 3 weeks, remove for one week. Repeat with new Ring

Trial Locations (1)

97239

Oregon Health and Science University, Portland

Sponsors
All Listed Sponsors
collaborator

Oregon Clinical and Translational Research Institute

OTHER

lead

Oregon Health and Science University

OTHER